Inventaire - your friends and communities are your best library

Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1).

Author

Richard A. Larson

published in: Leukemia

date of publication: 2003-04-01

main subject: Philadelphia chromosome

Bibliographic databases:

Cites articles 51

Date

Title

Authors

1973-06-01

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
1988-04-01

Characteristics of accelerated disease in chronic myelogenous leukemia
1995-09-01

Chronic myeloid leukaemia: a therapeutic challenge
1995-02-01

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service
1996-05

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
1996-05-01

Chronic myelogenous leukemia: a review
1997-10-01

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

, , , ,
1997-07-01

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group
1998-06-01

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group
1998-08-01

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCR
1998-02-01

Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy
1998-10-01

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
1998-01-01

Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy,Molecular Monitoring of Residual Disease in Chronic Myelogenous Leukemia Patients After Therapy
1998-04-01

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

,
1998-04-01

High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase
1999-04-01

Chronic myeloid leukemia
1999-12-01

Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
1999-11-01

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
2000-06-01

Detection and quantification of residual disease in chronic myelogenous leukemia

,
2000-10-01

Non-myeloablative stem cell transplants
2000-01-01

Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
2000-09-01

Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Chronic myeloid leukemia trialists' collaborative group
2000-04-01

Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia

,
2000-11-01

Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies
2000-02-01

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
2001-11-01

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

, , ,
2001-04-01

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
2001-04-05

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
2001-10-01

Chronic myeloid leukemia: current treatment options
2001-10-01

Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation
2001-12-01

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase
2001-11-01

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction

Article -

Welcome to inventaire

The library of your friends and communities

Learn more